tailieunhanh - Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

Several major randomized control studies have demonstrated that mepolizumab, an anti-IL-5 monoclonal antibody, is effective for patients with severe eosinophilic asthma who show exacerbation or require systemic corticosteroid maintenance therapy. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN